Banner
Home

Focus


DEA Reschedules Epidiolex, Paving the Way to Market Print E-mail
Written by FHI's Week in Review   
Monday, 01 October 2018 00:00
 
Megan Brooks reports for Medscape on 9.27.18:
 
The U.S. Drug Enforcement Administration (DEA) has rescheduled the epilepsy cannabidiol (CBD) drug Epidiolex (GW Pharmaceuticals) from Schedule I to Schedule V, the classification with the lowest degree of restriction - paving the way to market for the cannabis-based treatment, the company has announced. As reported by Medscape Medical News, the U.S. Food and Drug Administration (FDA) approved the drug in June for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome in patients aged 2 years and older. The approval followed a unanimous thumbs up by an FDA advisory committee in April.
 
Read more in the current issue of Week in Review>> https://conta.cc/2DK21h5
 
Last Updated on Monday, 01 October 2018 17:50
 
These Are the Economies With the Most (and Least) Efficient Health Care Print E-mail
Written by FHI's Week in Review   
Monday, 24 September 2018 17:36
 
Bloomberg published its annual global health analysis on September 19. As usual, it's depressing news for Americans. According to authors Lee J. Miller and Wei Lui:

The U.S. will cost you the most for treatment, both in absolute terms and relative to average incomes, while life expectancy of Americans -- about 79 years -- was exceeded by more than 25 countries and territories, according to an annual Bloomberg analysis in almost 200 economies.
 
Read more in the current issue of Week in Review>>
Last Updated on Friday, 26 October 2018 11:37
 
Opioid Crackdown Nets South Florida Doctor as Efforts Intensify Print E-mail
Written by Vitale Health Law   
Tuesday, 18 September 2018 17:27
 
A South Florida doctor is the latest to be sentenced for his role in the illegal distribution of opioids. Earlier this month, Dr. Andres Mencia of Fort Lauderdale was sentenced to more than six years in prison, after being convicted by a federal jury of taking part in a conspiracy to distribute a controlled substance.
 
Mencia's arrest and conviction are part of a large scale war on illegal opioid trafficking. In April, the Drug Enforcement Administration (DEA) announced it had reached a prescription drug information-sharing agreement with 48 Attorneys General to share prescription drug information with one another to aid investigations. According to evidence presented during his trial, Dr. Mencia ran Adult & Geriatric Institute of Fort Lauderdale where, between January 2014 and October 2017, he and others in his office performed "sham" consultations with cash-paying patients. These "consultations," according to evidence presented during the trial, were for the intended purpose of improperly issuing prescriptions for opioids and other narcotics, including Oxycodone, OxyContin and Percocet, in exchange for cash.

Read More
 
Last Updated on Tuesday, 18 September 2018 17:31
 
Mark Zuckerberg is selling up to $13 billion of Facebook stock to fund an ambitious project to end disease Print E-mail
Written by FHI's Week in Review   
Monday, 17 September 2018 17:31
 
A CNBC article published online 9.15.18 showcases some of the incredible things Facebook's founder and wife are doing with their spare cash.

The heightened focus on U.S. healthcare system's fundamental issue (too much money spent--almost 20% of GDP and growing-combined with mediocre outcomes- compared to other first world nations) is gathering momentum. Obamacare and the subsequent Repeal and Replace initiative by Republicans has shined a bright light on this dysfunctional industry.
 
Read more in the current issue of Week in Review>>
 
Last Updated on Monday, 15 October 2018 11:19
 
Update on Florida Workers’ Comp Print E-mail
Written by Tom Murphy | Danna-Gracey   
Wednesday, 12 September 2018 12:59
 
The Florida Department of Insurance, at the recommendation of the National Council on Compensation Insurance (NCCI), has approved and implemented a total of almost 12% in premium-rate decreases since January 1, 2018. In my recent conversations with a number of experts in the workers’ comp arena, it looks like there may be another rate decrease in 2019. For those of us in the industry this is welcome news for all businesses and medical practices in Florida. The reality is that the 2016 Florida Supreme Court decisions are impacting the workers’ comp system in ways that have not been realized by the carriers due to the nature of the system taking a few years to catch up to the impact of an increasing number of claims and higher payments to attorneys and injured workers.

The carriers and defense attorneys we work with have confirmed the increase in the claims they are receiving as well as the demand for benefits. These increases will ultimately lead to higher costs to the carriers and the overall system and will eventually show up in the form of rate increases for everyone buying coverage. These eventual rate increases will continue until the legislature decides to implement changes to counter the Florida Supreme Court decisions.

We also want to clear up some confusion about medical practices and small businesses that utilize PEOs or payroll companies. No practice or business is required to use a PEO or payroll company to service its workers’ comp coverage. You can remain with your workers’ comp insurance company and enjoy very beneficial dividend plans while having the same options, including “pay as you go” to simplify your premium payments. Some unscrupulous PEOs and payroll companies have been less than transparent with these details and want you to believe that the only way you can get a “pay as you go” option is to purchase their workers’ comp coverage, which is not true.
~~~~~~~~~~~~~~~
Contact Tom
tom@dannagracey.com
Phone: 800.966.2120

Last Updated on Wednesday, 12 September 2018 13:23
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 10 of 135


Banner
Website design, development, and hosting provided by
Netphiles